BioCryst Pharmaceuticals
BCRX
#5073
Rank
C$2.20 B
Marketcap
C$10.49
Share price
-3.07%
Change (1 day)
-4.61%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of September 2025 : C$0.61 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are C$0.61 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31C$0.70 B2.64%
2023-12-31C$0.68 B-8.13%
2022-12-31C$0.74 B-0.43%
2021-12-31C$0.74 B75.63%
2020-12-31C$0.42 B86.43%
2019-12-31C$0.22 B14.45%
2018-12-31C$0.20 B-10.75%
2017-12-31C$0.22 B85.62%
2016-12-31C$0.12 B-28.87%
2015-12-31C$0.16 B6.86%
2014-12-31C$0.15 B205.36%
2013-12-31C$52.01 M-8.93%
2012-12-31C$57.11 M-31.7%
2011-12-31C$83.62 M-23.57%
2010-12-31C$0.10 B-26.88%
2009-12-31C$0.14 B45.29%
2008-12-31C$0.10 B-27.67%
2007-12-31C$0.14 B78.55%
2006-12-31C$79.73 M-30.99%
2005-12-31C$0.11 B196.3%
2004-12-31C$38.99 M-0.11%
2003-12-31C$39.03 M-40.15%
2002-12-31C$65.22 M-30.71%
2001-12-31C$94.14 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Repligen
RGEN
C$4.03 B 554.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
C$4.82 B 682.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
C$12.19 M-98.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$1.63 B 164.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$80.86 B 13,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C$0.89 B 45.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$113.91 B 18,371.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
C$2.01 B 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C$28.09 M-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA